Wall Street is betting tens of millions of dollars on psychedelic drugs that backers say could treat mental illness for a fraction of what it costs to do therapy with better-known treatments.
Transcend Therapeutics Inc. raised $40 million from venture-capital investors in January to develop a post-traumatic stress disorder treatment that its 29-year-old CEO Blake Mandell says would require about half the amount of therapy as MDMA, or ecstasy, a popular hallucinogen. Gilgamesh Pharmaceuticals Inc. and Lusaris Therapeutics Inc. have announced capital raises of about $100 million since November for similar products addressing depression.
24World Media does not take any responsibility of the information you see on this page. The content this page contains is from independent third-party content provider. If you have any concerns regarding the content, please free to write us here: contact@24worldmedia.com
The post Today’s page 1: 6-12-26 appeared first on Itemlive. Source...
For Jessica Cruz, also known as Ephemeral Jess, art has never been just about paint on a canvas. It’s...
LYNN — Talk about a way to end a meeting. Dr. Molly Cohen was unanimously appointed to serve as the...
NORTH ANDOVER — Beneath the bright lights at Merrimack College, St. Mary’s girls flag football team...
MARBLEHEAD — The Veterans of Foreign Wars Post 2005 will mark a major milestone in the nation’s...
To the editor: In November 2024, Massachusetts voters overwhelmingly approved Question 1, authorizing the...
Bulgarian woman building a business in Saugus
Beth Anderson: Banning cell phones in our schools had a postivie impact on teaching and learning
Lynn’s Crisman receives national teaching award
Police Logs: June 10, 2026
Scooter ride ends at Nahant Police Station
Marblehead addresses use of $15M override
LHAND awards scholarships to 53 Lynn seniors
Lynn students row, row, row their boat
Commentary: Mamdani is about to make housing even more expensive
Swampscott plays it smart on affordable housing
Four Marblehead runners racing to Nike Nationals
Historic Greenport shipyard sale could test landmark working waterfront law